Table 2.
Multivariable Analysis of Adherence to Statin Medications among Individuals with Vs. Without Psychiatric Illness (N=1,1071
| Characteristic | Model 1 | Model 2 | Model 3 | |||
|---|---|---|---|---|---|---|
|
| ||||||
| Adjusted OR (CI) | P | Adjusted OR (CI) | P | Adjusted OR (CI) | P | |
|
| ||||||
| Schizophrenia Diagnosis | 1.46 (1.13–1.89) | 0.004 | 1.58 (1.21–2.05) | 0.001 | 1.29 (0.98–1.70) | NS |
|
| ||||||
| Clinical and health service use characteristics | ||||||
| Medical comorbidity | 1.13 (1.04–1.24) | 0.01 | 1.02 (0.93–1.12) | NS | ||
| Any ER visits, past 6 mos | 1.48 (1.07–2.07) | 0.02 | 1.60 (1.13–2.25) | 0.01 | ||
| Any Hospitalization, past 6 mos | 1.13 (0.72–1.79) | NS | 1.38 (0.85–2.24) | NS | ||
| Number of outpatient clinic visits, past 6 mos | 0.99 (0.98–1.00) | NS | 0.98 (0.96–0.99) | 0.001 | ||
|
| ||||||
| Medication regimen characteristics | ||||||
| Number of medications filled, past 6 mos | 1.16 (1.11–1.21) | 0.001 | ||||
1
Models also controlled for patients’ demographic characteristics (age, neighborhood SES and race/ethnicity) and site.